Status:
COMPLETED
Significance of Cortactin Expression in Colorectal Adenocarcinomas
Lead Sponsor:
Sohag University
Conditions:
Cancer Colon
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
Colorectal carcinoma is one of the most aggressive malignant epithelial neoplasms affecting the gastrointestinal tract. The incidence of colorectal carcinoma is obviously increasing in developing coun...
Detailed Description
Colorectal carcinoma is a highly lethal malignant epithelial tumor involving humans. The incidence of colorectal carcinoma is steadily increasing in developing countries, this could be assigned to low...
Eligibility Criteria
Inclusion
- patients with colorectal carcinomas who underwent colectomy operations.
Exclusion
- specimens obtained by lower endoscopy only, patients who received pre-operative chemotherapy.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05225870
Start Date
January 1 2021
End Date
December 30 2021
Last Update
July 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maisa Hashem Mohammed
Sohag, Egypt, 82524